INTRODUCTION
Receptors that stimulate the formation of inositol 1,4,5-trisphosphate (IP $ ) typically evoke both release of Ca# + from intracellular stores and Ca# + entry across the plasma membrane [1] . Capacitative Ca# + entry (CCE) channels, which open in response to a signal generated by depletion of intracellular Ca# + stores, are widely assumed to provide a major route for such Ca# + entry [2] . Experiments with thapsigargin, which allow intracellular Ca# + stores to be emptied without receptor activation, provide the most persuasive evidence in favour of a significant role for CCE. Such experiments have often shown that empty Ca# + stores can evoke Ca# + entry that is at least as great as that evoked by activation of receptors that stimulate IP $ formation [2] . However, many cells also express non-capacitative Ca# + entry (NCCE) pathways [3] [4] [5] , some of which are activated by arachidonic acid [6, 7] . The physiological roles of these different Ca# + entry pathways are unclear [3, 8, 9] .
A7r5 vascular smooth muscle cells, in common with most other cells [10] , express a CCE pathway that is activated after depletion of intracellular Ca# + stores [11] . In A7r5 cells, this CCE pathway is permeable to Mn# + , Ba# + and Ca# + , but not to Sr# + , and it is blocked selectively and essentially irreversibly by 1 µM Gd$ + [5] . Our previous work [5, 11] established that Arg)-vasopressin (AVP), via its interaction with vasopressin V "A receptors [12] , also stimulates NCCE. The NCCE pathway is permeable to Sr# + , Ca# + and Ba# + , but not to Mn# + , and it is 3 , inositol 1,4,5-trisphosphate ; I ARC , arachidonic acid-activated Ca 2 + entry channel ; LOE-908, (R,S)-(3,4-dihydro-6,7-dimethoxyisochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid mesylate ; NCCE, non-capacitative Ca 2 + entry ; RHC-80267, 1,6-bis(cyclohexyloximinocarbonylamino)hexane ; U73122, 1-o6([17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino)hexylq-1H-pyrrole-2,5-dione. 1 To whom correspondence should be addressed (e-mail cwt1000!cam.ac.uk).
inhibitors to resolve the contributions of each Ca# + entry pathway during stimulation with AVP, we establish that reciprocal regulation of CCE and NCCE by arachidonic acid ensures that only NCCE is active in the presence of AVP, whereas CCE is active only after its removal. NCCE and CCE are therefore activated in a strict temporal sequence : NCCE first and then CCE. Because Ca# + passing through different Ca# + entry pathways can selectively regulate different responses, reciprocal regulation of CCE and NCCE may allow a stimulus to first evoke a response and then recruit actively a different response when the stimulus is removed.
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reversibly blocked by a high concentration (100 µM) of Gd$ + . NCCE is activated, without the need for emptying of intracellular Ca# + stores, by arachidonic acid released by the sequential activities of phospholipase C and diacylglycerol (DAG) lipase [5] , the path by which most DAG is metabolized in vascular smooth muscle [13] . Activation of NCCE by AVP is therefore prevented by RHC-80267, a selective inhibitor of DAG lipase [5] . In A7r5 cells, therefore, both limbs of the phosphoinositide pathway regulate distinct Ca# + entry pathways : IP $ activates CCE by emptying intracellular Ca# + stores, and DAG provides the arachidonic acid that causes activation of NCCE (Figure 1a) . In the present study, we address the interplay between CCE and NCCE in A7r5 cells.
MATERIALS AND METHODS

Fura 2 measurements of bivalent cation entry in A7r5 cells
A7r5 cells were cultured on glass coverslips, loaded with fura 2 and mounted in an optical cuvette in the light path of a fluorescence spectrometer (F-4500 ; Hitachi), as described previously [5] . The cells were excited with light of appropriate wavelength (340 nm and 380 nm for Ca# + recordings ; 360 nm for Mn# + and Ba# + recordings), and emitted light was collected at a wavelength of 510 nm. After correction for autofluorescence, calibrations of fluorescence ratios (R $%!/$)! ) to cytosolic free Ca# + concentration ([Ca# + ] c ) were performed using look-up tables Because the voltage-gated L-type Ca# + channels of A7r5 cells are often spontaneously active [14] and are regulated by AVP [15] , we included verapamil (10 µM) in all media to inhibit completely L-type Ca# + channels. The effectiveness of this inhibition was verified by demonstrating that the increase in [Ca# + ] c (220p13 nM, n l 3), which was evoked by addition of HBS containing 53 mM KCl (to depolarize the plasma membrane), was abolished by 10 µM verapamil (5p1 nM).
Figure 1 CCE and NCCE in A7r5 cells
Where appropriate, CCE was maximally activated by pretreating cells (10 min) with ionomycin (1 µM) and thapsigargin (1 µM). This procedure completely emptied the hormone-sensitive intracellular Ca# + stores : the increase in [Ca# + ] c evoked by AVP (100 nM) in Ca# + -free HBS was 431p24 nM (n l 3) in normal cells, and 5p2 nM in cells after thapsigargin\ionomycin treatment. Ionomycin was used in these experiments because thapsigargin alone could only empty the stores slowly. Subsequent experiments ( Figure 1 ) established that the only bivalent cation entry activated by this treatment has the properties of CCE, suggesting that pretreatment with ionomycin does not directly lead to it transporting bivalent cations across the plasma membrane ; other studies have reached a similar conclusion [16] .
For measurements of Mn# + entry via CCE, we established that the rate of quench of fura 2 fluorescence in the presence of Mn# + (50 µM) before emptying the intracellular stores (Q1) was indistinguishable from that recorded after thapsigargin\ionomycin treatment with Ca# + entry pathways blocked by 100 µM Gd$ + (Q2 ; Q2\Q1 l 91p12 %, n l 3). In subsequent experiments, the basal rate of Mn# + entry was therefore determined at the end of each experiment in the presence of 100 µM Gd$ + . The effect of AVP on Mn# + entry via CCE was measured by perfusing thapsigargin\ionomycin-treated cells with Ca# + -free HBS containing 50 µM MnCl # for 120 s ; AVP (or other additions) was present for the final 60 s. Least-squares linear regression was then used to define the rate of fluorescence quench during the final 20 s of the first 60 s interval (R1, i.e. control rate of Mn# + entry via CCE) and then during the final 20 s of the second 60 s interval (R2, i.e. AVP-modulated rate of Mn# + entry via CCE) (see Figure 4a for a typical protocol). Under control conditions, rates of Mn# + entry via CCE were similar during the first and second recording intervals (R2\R1 l 96p9 %, n l 5). After subtracting the basal rate of Mn# + entry from all recordings, the ratio of the rates of Mn# + entry during the two intervals (R2\R1) was used to quantify the effects of AVP (or other drugs) (see Figure 4c ).
To reverse rapidly the effects of AVP (see Figure 7) , removal of AVP from the perfusing medium was accompanied by addition of a high concentration (100 nM) of a peptide antagonist of the vasopressin V "A receptor [17] (see below). All traces are typical of at least three experiments, and results are expressed as the meanspS.E.M for at least three independent experiments.
Materials
A7r5 cells were originally from the A.T.C.C. Arachidonic acid, 1,6-bis(cyclohexyloximinocarbonylamino)hexane (RHC-80267), 1-o6([17β -3 -methoxyestra -1,3,5(10) -trien -17 -yl]amino)hexylq -1H-pyrrole-2,5-dione (U73122) and verapamil were from Calbiochem-Novabiochem (Nottingham, U.K.). 2-Aminoethyl diphenylborane (' 2-APB '), AVP and the selective peptide
acetamid mesylate (LOE-908) was generously given by Boehringer Ingelheim (Biberach an der Riss, Germany). The targets of the drugs used are shown in Figure 1(a) . All other manufacturers have been reported previously [5] .
RESULTS AND DISCUSSION
CCE and NCCE do not operate independently
Our previous attempts [5] to resolve the relative roles of the CCE and NCCE pathways to the Ca# + signals evoked by AVP were hampered by lack of a selective inhibitor of the NCCE pathway. The results shown in Figures 1(b) and 1(d) agree with previous work [5] , demonstrating that 1 µM Gd$ + selectively blocks CCE without affecting NCCE ; 2-aminoethyl diphenylborane (100 µM) also selectively blocks CCE, without affecting NCCE (results not shown), in accordance with results from other cell types [8] . Conversely, LOE-908 (30 µM), which has been used to inhibit non-selective cation currents [18] , blocks NCCE without affecting CCE (Figures 1c and 1e) . In subsequent experiments, we used 1 µM Gd$ + to selectively block CCE, and LOE-908 (30 µM) to selectively block NCCE.
Maximal activation of CCE (using thapsigargin\ionomycin) evokes a 5-fold larger increase in [Ca# + ] c (459p32 nM) compared with maximal activation of NCCE (90p10 nM) (Figure 2b ). Yet paradoxically, in both A7r5 [5, 18] and other cell types [8, 19] , it has been suggested that CCE is unlikely to provide the major route for the Ca# + entry evoked by physiological stimuli. The experiments described below attempt to resolve this apparent paradox.
We established previously [5] a variant of the A7r5 cell line in which most responses to AVP were normal, but AVP failed to stimulate NCCE (Figure 2a) . Because exogenous arachidonic acid activated NCCE in these cells, we suggested that these variant cells lack DAG lipase [5] . The variant cells therefore afford the opportunity to address the role of DAG lipase in regulating AVP-evoked Ca# + entry. We expected the Ca# + entry evoked by AVP to be greater in normal A7r5 cells (where both CCE and NCCE could be activated) compared with in the variant cells (where only CCE could be activated). Instead, although the Ca# + entry evoked by depletion of intracellular Ca# + stores was similar in the two cell lines (Figure 2a) , the Ca# + entry recorded in thapsigargin-treated cells in the presence of AVP was much larger in cells lacking DAG lipase than in normal cells (Figures 2a and 2b) .
Ba# + permeates both pathways, but it is not transported by Ca# + pumps [11] ; therefore Ba# + allows the activities of the Ca# + entry pathways to be measured free of any effects of AVP on Ca# + extrusion [20] . Figure 2 (c) demonstrates that maximal activation of either CCE (using thapsigargin\ionomycin) or NCCE alone (by AVP after blockade of CCE with 1 µM Gd$ + ) stimulates Ba# + entry. Furthermore, the rate of Ba# + entry through CCE is approx. 5-fold greater than that through NCCE (Figure 2d) , consistent with the results obtained by measuring Ca# + signals, where the peak increases in [Ca# + ] c evoked by the two pathways also differed by approx. 5-fold (Figure 2b) . However, the Ba# + entry evoked by AVP after thapsigargin treatment is much smaller than that evoked by thapsigargin alone (Figure 2c) . Hence, irrespective of whether Ca# + (Figure 2b ) or Ba# + (Figure 2d ) entry is used to assess the activities of the two pathways, our results concur in demonstrating that the CCE and NCCE pathways do not operate independently. Instead AVP both stimulates NCCE, as reported previously [5, 11] , and inhibits CCE. Our results with the variant cell line (Figure 2b ) suggest that DAG lipase is required for both effects of AVP.
In the experiments described so far, CCE was activated pharmacologically by pretreating cells with thapsigargin\ionomycin, but it was important to resolve whether AVP was capable of activating CCE when the inhibitory effect of AVP was prevented. To address this issue, A7r5 cells were stimulated with AVP in the presence of RHC-80267 (50 µM) to prevent activation of DAG lipase (Figure 3a) . Under these conditions, a maximally effective concentration of AVP (100 nM) stimulated Ca# + entry (increase in [Ca# + ] c l 335p22 nM, n l 3), which is comparable with that evoked by thapsigargin\ionomycin (349p7 nM), and in both cases the Ca# + signal was reversed by addition of 1 µM Gd$ + (Figure 3b ). The concentration of AVP that caused halfmaximal release of the intracellular Ca# + stores (EC &! l 22p 10 nM ; Figure 3c ) was similar to that required for half-maximal activation of CCE : the CCE signal evoked by 20 nM AVP was 44p7 % of that evoked by 100 nM AVP (Figure 3b ). These results are important because they demonstrate that, when DAG lipase is inhibited, the emptying of intracellular Ca# + stores by AVP is closely coupled to activation of CCE.
Arachidonic acid co-ordinates the two Ca 2 + entry pathways by activating NCCE and inhibiting CCE
Pretreatment of cells with thapsigargin\ionomycin emptied completely the AVP-sensitive intracellular Ca# + stores (see the Materials and methods section), and maximally activated Mn# + entry via the CCE pathway. AVP (100 nM) inhibited this capacitative Mn# + entry (Figures 4a and 4b) , and the sensitivity of this inhibition to AVP (EC &! l 19p2 nM) was the same as that for the effect of AVP on release of Ca# + from intracellular stores (EC &! l 22p10 nM ; Figure 3c ) and Ca# + entry via NCCE (EC &! l 18p2 nM ; Figure 4d ). Inhibition of Mn# + entry via CCE by AVP was reversed by U73122 (30 µM, an inhibitor of phospholipase C) and by RHC-80267 (Figures 4b and 4c lipase, AVP had no effect on Mn# + entry via the CCE pathway (Figure 4c) . Hence, the results with both selective pharmacological inhibitors and the mutant cell line are consistent in suggesting that both phospholipase C and DAG lipase are required for AVP to inhibit CCE.
AVP still inhibited completely Mn# + entry via the CCE pathway when extracellular Na + was replaced with the impermeant cation N-methyl--glucamine (Figure 4c ), indicating that inhibition of CCE by AVP was not due to the depolarization of the plasma membrane caused by Na + entry via the NCCE pathway. The lack of detectable CCE in cells stimulated with AVP in the presence of LOE-908 to block the NCCE pathway (see Figure 7) further substantiates this conclusion.
We were also concerned that inhibition of a K + channel (possibly by arachidonic acid [21] ) might have depolarized the plasma membrane, and thereby diminished the electrochemical gradient for Ca# + entry. To address this possibility, CCE was examined under conditions where the K + gradient across the plasma membrane was collapsed by reversing the normal extracellular concentrations of KCl (to 135 mM) and NaCl (to 5.9 mM). As expected, these conditions reduced greatly the amplitude of the CCE Ca# + signal (results not shown), but by increasing the extracellular CaCl # concentration (to 10 mM) the CCE signal was restored to a level similar to that recorded in normal HBS (Figures 5a and 5b) . Despite the absence of an inwardly directed K + gradient across the plasma membrane and a complete block of the NCCE pathway by LOE-908, addition of AVP (100 nM) rapidly inhibited Ca# + entry via CCE (Figures 5a and 5b) . Finally, when we used the Mn# + -evoked quench of fura 2 to record the activity of the CCE pathway, AVP inhibited completely the Mn# + entry evoked by store depletion, despite the presence of LOE-908 and with the K + gradient across the plasma membrane collapsed (Figure 5c ). Under these conditions, emptying of intracellular Ca# + stores caused a 5.8p0.9-fold (n l 3) increase in the rate of Mn# + entry, but AVP then caused the stimulated rate of Mn# + entry to fall to only 3p4 % of the rate recorded before AVP addition. These findings indicate that the ability of AVP to inhibit the Ca# + (or Mn# + ) signals evoked by CCE resulted from an inhibition of the CCE pathway, and not from a decrease in the driving force for Ca# + entry mediated by either inhibition of K + channels or activation of non-selective cation channels.
Arachidonic acid, the immediate product of DAG lipase activity, has been reported to inhibit CCE in some cells [22, 23] . Because arachidonic acid is lipophilic and would normally be produced at the plasma membrane (from DAG in A7r5 cells) and then affect Ca# + channels in the plasma membrane, it is impossible to present exogenous arachidonic acid in a way that mimics faithfully the arachidonic acid made in response to receptor activation [8] . Therefore we examined the effects of only a single high concentration of arachidonic acid (50 µM) on the two Ca# + entry pathways, and exploited the distinct pharmacological properties of CCE and NCCE to provide evidence for the selective actions of arachidonic acid. In cells where the intracellular stores had been completely emptied by thapsigargin\ionomycin, and with NCCE blocked by LOE-908 (30 µM), arachidonic acid inhibited CCE (Figure 6a) . Conversely, in thapsigargin\ionomycin-treated cells with the CCE blocked by 1 µM Gd$ + , arachidonic acid rapidly activated Ca# + entry ( Figure  6a ). We demonstrated previously [5] that arachidonic acid stimulated Sr# + entry, but not Mn# + entry, and that arachidonic acid-evoked Ca# + entry was inhibited by 100 µM Gd$ + . Each of these characteristics is consistent with the selective activation of NCCE by arachidonic acid. We have now extended the characterization by demonstrating that arachidonic acid-evoked Ca# + entry is also selectively inhibited by LOE-908. After exposure to arachidonic acid for 150 s, the increase in [Ca# + ] c was 112p17 nM (n l 3) (similar to the response when NCCE was maximally activated by AVP, 90p10 nM ; Figure 2b ), but in the presence of 30 µM LOE-908, the increase was only 3p1 nM. Reciprocal control of Ca 2 + entry pathways We conclude that arachidonic acid, which is released from DAG by DAG lipase, co-ordinates the activities of the two AVPregulated Ca# + entry pathways by stimulating NCCE and inhibiting CCE (Figure 6b) . Thapsigargin, by providing only the stimulatory element of the signals that would pass normally from receptors to the CCE pathway (i.e. store depletion), exaggerates the contribution of CCE to receptor-regulated Ca# + entry.
Rapid switching between Ca 2 + entry pathways after addition and removal of AVP
To resolve the relative contributions of CCE and NCCE to the Ca# + signals evoked by a physiological stimulus, cells were exposed to a maximal or submaximal concentration of AVP under conditions where both, neither or only one of the two Ca# + entry pathways were selectively blocked ( Figure 7) . The Ca# + signals recorded in the presence of AVP were similar whether both Ca# + entry pathways were blocked (100 µM Gd$ + ) or only NCCE was blocked (30 µM LOE-908) ; in each case the increase in [Ca# + ] c resulted entirely from release of intracellular Ca# + stores. Furthermore, the more sustained Ca# + signals evoked by AVP were unaffected by blocking of the CCE pathway. Our results therefore demonstrate that, in the presence of either concentration of AVP, the stimulated Ca# + entry is mediated entirely by NCCE (Figure 7) .
After rapid removal of AVP, Ca# + entry via NCCE was rapidly switched off and a large Ca# + signal mediated by CCE was observed, which terminated as the intracellular stores refilled. This CCE signal was most pronounced in cells stimulated with AVP when NCCE was blocked (Figure 7 ). Under these conditions, there can have been no Ca# + entry via NCCE during the early phase of the response to refill the intracellular stores, but the empty stores would have been unable to evoke CCE until relieved of the inhibition provided by arachidonic acid ( Figure  7a ). These results therefore establish that inhibition of CCE by AVP is rapidly reversible, which is consistent with the rapid metabolism of arachidonic acid.
The results with a submaximal concentration of AVP are more significant, because they demonstrate that under conditions where the NCCE pathway had been active continuously during the early phase of the response, there was a significant stimulation of Ca# + entry via CCE when AVP was removed (Figure 7b ). With sub-maximal stimulation, therefore, all Ca# + entry is via NCCE when AVP is present, but this Ca# + entry is insufficient to refill the intracellular Ca# + stores. After removal of AVP, NCCE rapidly switches off and CCE is rapidly activated and remains active until the stores have refilled.
Conclusions
Cytosolic Ca# + is potentially toxic and with Ca# + entry pathways providing access to a limitless source of Ca# + , it is to be expected that cells tightly regulate each Ca# + entry pathway [3] , but it is [24] , switching between voltage-gated and voltage-independent pathways after depolarization (ii ) [25] , and the reciprocal regulation of CCE and NCCE (iii ) [26] , have each been suggested to co-ordinate Ca 2 + entry via different pathways. (b) We suggest that reciprocal regulation of CCE and NCCE in A7r5 cells may allow active switching between stimulation (contraction for vascular smooth muscle cells mediated by NCCE) when the receptor is occupied (ii ) and recovery (relaxation mediated by CCE) when AVP dissociates from its receptor (iii ).
also important that the activities of different Ca# + entry pathways are effectively co-ordinated (Figure 8a) .
In myenteric neurones, activation of a subclass of purinoceptor (P2X # ) by ATP is conformationally coupled to inhibition of associated nicotinic acetylcholine receptors, such that the synaptic currents (carried partly by Ca# + ) evoked by simultaneous activation of both receptors are less than the sum of the currents evoked by independent activation of each receptor [24] (Figure  8a ). In colonic smooth muscle, the Ca# + entry that drives refilling of intracellular Ca# + stores switches from a dependence on CCE to L-type Ca# + channels, as the membrane depolarizes [25] and voltage-gating of the L-type channel compensates for the reduced driving force for Ca# + entry (Figure 8a ). In HEK-293 cells, the Ca# + entry evoked by modest stimulation of muscarinic acetylcholine receptors appears to be mediated by an arachidonic acid-activated Ca# + entry channel (I ARC ), whereas CCE is almost entirely responsible for the Ca# + entry evoked by more intense stimulation [26] (Figure 8a ). The mechanisms controlling this switch from NCCE to CCE are controversial. Inhibition of I ARC by sustained increases in [Ca# + ] c [26] , or some unidentified consequence of activating CCE [23] , have each been proposed to attenuate NCCE as the stimulus intensity increases. The lack of CCE during weak stimulation is likely to result simply from inadequate emptying of intracellular Ca# + stores [26] , but active repression of CCE by arachidonic acid has also been suggested [23] , although there is no evidence to suggest that activation of muscarinic receptors inhibits CCE in these cells [26] . In summary, co-ordinated regulation of different Ca# + entry pathways is likely to be widespread, but the mechanisms are incompletely understood.
We chose to measure cytosolic Ca# + signals (rather than currents), focused on the effects of a physiological extracellular stimulus (AVP), and used thoroughly characterized inhibitors of the Ca# + entry pathways to define the physiological roles of CCE and NCCE in mediating cytosolic Ca# + signals in A7r5 cells. We conclude that arachidonic acid, released by the sequential activities of phospholipase C and DAG lipase, co-ordinates the contributions of two receptor-regulated Ca# + entry pathways, such that each is activated in a specific temporal sequence. By activating NCCE and simultaneously inhibiting CCE, arachidonic acid ensures that when the extracellular stimulus is present, only the NCCE pathway contributes to Ca# + entry, and CCE contributes only after removal of the stimulus. CCE may therefore, as commonly supposed [3] , allow refilling of intracellular stores after removal of a stimulus. More importantly, because different Ca# + entry pathways can selectively regulate different intracellular responses [27, 28] , reciprocal regulation of the two pathways may allow an extracellular stimulus to abruptly initiate a response (via NCCE) when it binds to its receptor and then reverse it actively (via CCE) when the stimulus dissociates (Figure 8b) .
In vascular smooth muscle, Ca# + is the major stimulus for contraction, and cAMP and cGMP cause relaxation [29] . Ca# + entry via the CCE pathway selectively stimulates certain isoforms of adenylate cyclase [30] and constitutive NO synthase [27] (leading to cGMP formation) ; both enzymes are expressed in vascular smooth muscle [29, 31] . We speculate, therefore, that AVP may cause contraction by stimulating Ca# + entry via the NCCE pathway, and removal of AVP may then cause relaxation by activating CCE (Figure 8b ). This work was supported by The Wellcome Trust.
